# Assessing Quality of Life in PACS1 Syndrome Using the KidsLife Scale from Mothers’ and Fathers’ Perspectives

**Authors:** Julia del Rincón, Laura Trujillano, Cristina Lucia-Campos, Isabel Xiang, Ana Latorre-Pellicer, Beatriz Puisac, María Arnedo, Marta Gil-Salvador, Laura Acero, Pilar Pamplona, Ariadna Ayerza-Casas, Feliciano J. Ramos, Juan Pié

PMC · DOI: 10.3390/bs16020250 · Behavioral Sciences · 2026-02-09

## TL;DR

This study evaluates the quality of life in individuals with PACS1 Syndrome using the KidsLife scale, highlighting areas of need and the impact on families.

## Contribution

The study is the first to systematically assess quality of life in PACS1 Syndrome using a validated scale and caregiver reports.

## Key findings

- Individuals with PACS1 Syndrome showed lower QoL scores in autonomy-related domains compared to others with intellectual disabilities.
- Families often reduce working hours due to caregiving demands, with mothers disproportionately affected.
- Despite challenges, social inclusion and material well-being were relatively preserved in this population.

## Abstract

PACS1 Syndrome is an ultra-rare neurodevelopmental disorder characterized by intellectual disability, behavioral disturbances, and multisystem involvement. While clinical knowledge is growing, its impact on quality of life (QoL) has not been systematically evaluated, and it is critical to understand the lived experience and psychosocial well-being of these individuals beyond strictly medical outcomes. This study aimed to assess QoL in individuals aged 4–21 years with PACS1 Syndrome using the validated KidsLife scale, proxy-reported by primary caregivers, given the intellectual disabilities and communicative limitations of this population. Twenty-one participants from Spain and other countries were recruited through the Spanish PACS1 Association, and 39 questionnaires from mothers and fathers were analyzed. The KidsLife scale provides standardized scores across eight QoL domains and a global QoL index (QoLI). The mean QoLI was 48.1 ± 28.3, slightly below the median for individuals with intellectual disability, but higher than other neurodevelopmental disorders such as Cornelia de Lange Syndrome. The findings revealed a pattern: while domains related to social inclusion, rights, and physical and material well-being were relatively preserved, reflecting adequate care and access to resources, the most significant compromises were observed in autonomy-related domains, specifically self-determination, interpersonal relationships, and personal development. Most individuals showed a high degree of dependency, and those with greater dependency exhibited lower QoL scores. This situation led more than half of families to reduce their working hours, with caregiving responsibilities disproportionately falling on mothers. Although no statistically significant differences were found between parental ratings, mothers tended to report higher QoL. These findings reflect the substantial functional impact of PACS1 Syndrome and emphasize the need for multidisciplinary support to improve autonomy, social participation, and overall well-being.

## Linked entities

- **Genes:** PACS1 (phosphofurin acidic cluster sorting protein 1) [NCBI Gene 55690]
- **Diseases:** Cornelia de Lange Syndrome (MONDO:0016033)

## Full-text entities

- **Genes:** PACS1 (phosphofurin acidic cluster sorting protein 1) [NCBI Gene 55690] {aka MRD17, SHMS}
- **Diseases:** PACS Syndrome (MESH:D013577), intellectual disabilities (MESH:D008607), ASD (MESH:D000067877), ataxia (MESH:D001259), rare (MESH:D035583), hypotonia (MESH:D009123), injury to (MESH:D014947), neurodegeneration (MESH:D019636), language delay (MESH:D007805), autism (MESH:D001321), Down Syndrome (MESH:D004314), impaired (MESH:D060825), dependency (MESH:D019966), behavioral disturbances (MESH:D001523), aggression (MESH:D010554), WS (MESH:D018980), motor skills (MESH:D019957), ocular, urogenital, or cardiac anomalies (MESH:D014564), monogenic disorder (MESH:D009358), gait instability (MESH:D043171), CdLS (MESH:D003635), Neurodevelopmental Disorder (MESH:D002658), genetic (MESH:D030342), seizures (MESH:D012640), cardiac, renal, and neurological comorbidities (MESH:D009461)
- **Chemicals:** PI19/247 (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** Arg203Trp

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937686/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12937686/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937686/full.md

---
Source: https://tomesphere.com/paper/PMC12937686